Apollomics, known in the stock market as APLM.US, has successfully achieved a significant regulatory milestone. The United States Securities and Exchange Commission (SEC), based in Washington, D.C., has granted Notice of Effectiveness to the company. This development came into effect on May 28, 2024, at 4:00 P.M. The form associated with this notice is F-3, which pertains to the registration of securities by foreign private issuers. The SEC's acknowledgment underlines Apollomics' compliance with necessary regulatory standards, marking an important step for the company's financial activities in the U.S. market. The file number associated with this notice is 333-279427, and the Central Index Key (CIK) for Apollomics is 0001878848.

Apollomics, known in the stock market as APLM.US, has successfully achieved a significant regulatory milestone. The United States Securities and Exchange Commission (SEC), based in Washington, D.C., has granted Notice of Effectiveness to the company. This development came into effect on May 28, 2024, at 4:00 P.M. The form associated with this notice is F-3, which pertains to the registration of securities by foreign private issuers. The SEC's acknowledgment underlines Apollomics' compliance with necessary regulatory standards, marking an important step for the company's financial activities in the U.S. market. The file number associated with this notice is 333-279427, and the Central Index Key (CIK) for Apollomics is 0001878848.